FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040338617> ?p ?o ?g. }

• W2040338617 endingPage "837" @default.
• W2040338617 startingPage "830" @default.
• W2040338617 abstract "The rates of cholesterol 7α-hydroxylation (the first and rate-limiting step of bile acid synthesis from cholesterol) were evaluated in vivo in patients administered bile acids with different structural properties, cholestyramine or simvastatin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Twenty-three subjects, with normal hepatic and intestinal functions, were studied in basal conditions and after one of the following treatment schedules, lasting 4 to 6 weeks: cholestyramine, 4 and 12 gm/day (four patients); ursodeoxycholic acid, 9 to 11 mg/kg/day (four patients); chenodeoxycholic acid, 12 to 15 mg/kg/day (five patients); deoxycholic acid, 8 to 10 mg/kg/day (four patients); and simvastatin, 40 mg/day (six patients). 7α-Hydroxylation of cholesterol was assayed by measuring the increase in body water tritium after intravenous bolus of cholesterol tritiated at the 7α position. Plasma bile acid composition, evaluated by gas-liquid chromatography, revealed a substantial enrichment of the recirculating pool by the administered bile acid, whereas treatment with cholestyramine decreased the content of dihydroxylated bile acids. Cholesterol 7α-hydroxylation increased in a dose-related manner after cholestyramine, in parallel with a decrease of cholesterol in total plasma and low-density lipoproteins (1.006 to 1.063 gm/ml). Hydroxylation rates decreased by an average of 47% with chenodeoxycholic acid and by an average of 78% with deoxycholic acid; ursodeoxycholic acid treatment did not affect 7α-hydroxylation significantly. Simvastatin markedly reduced plasma total and low-density lipoproteincholesterol but exerted no change on 7α-hydroxylation rates. Our results support the existence of a feedback inhibition exerted on cholesterol 7α-hydroxylation (and consequently on bile acid synthesis) by hydrophobic bile acids returning to the liver through the enterohepatic circulation. The finding emphasizes the importance of the physicochemical properties of bile acids in the regulation of hepatic cholesterol balance. Under these experimental conditions, inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and presumably reduced availability of newly synthesized cholesterol are not critical for bile acid synthesis. (HEPATOLOGY 1991;14:830–837)." @default.
• W2040338617 created "2016-06-24" @default.
• W2040338617 creator A5006020968 @default.
• W2040338617 creator A5025193144 @default.
• W2040338617 creator A5036912327 @default.
• W2040338617 creator A5050671359 @default.
• W2040338617 creator A5057513705 @default.
• W2040338617 creator A5057727335 @default.
• W2040338617 creator A5065857081 @default.
• W2040338617 creator A5069097596 @default.
• W2040338617 date "1991-11-01" @default.
• W2040338617 modified "2023-09-27" @default.
• W2040338617 title "Regulation of bile acid synthesis in humans: Effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7α-hydroxylation ratesin vivo" @default.
• W2040338617 cites W1507246517 @default.
• W2040338617 cites W1513741126 @default.
• W2040338617 cites W1532840606 @default.
• W2040338617 cites W1540063615 @default.
• W2040338617 cites W1566885967 @default.
• W2040338617 cites W1569714421 @default.
• W2040338617 cites W1584638689 @default.
• W2040338617 cites W1600065401 @default.
• W2040338617 cites W1600719794 @default.
• W2040338617 cites W1611880393 @default.
• W2040338617 cites W1823787769 @default.
• W2040338617 cites W1828402659 @default.
• W2040338617 cites W1914943665 @default.
• W2040338617 cites W1966012268 @default.
• W2040338617 cites W1975515702 @default.
• W2040338617 cites W1998600489 @default.
• W2040338617 cites W2006656480 @default.
• W2040338617 cites W2011752019 @default.
• W2040338617 cites W2016678257 @default.
• W2040338617 cites W2034507000 @default.
• W2040338617 cites W2041326815 @default.
• W2040338617 cites W2043775185 @default.
• W2040338617 cites W2045190945 @default.
• W2040338617 cites W2045845834 @default.
• W2040338617 cites W2071185141 @default.
• W2040338617 cites W2079358768 @default.
• W2040338617 cites W2088164016 @default.
• W2040338617 cites W2091783518 @default.
• W2040338617 cites W2100680747 @default.
• W2040338617 cites W2112768863 @default.
• W2040338617 cites W2128436815 @default.
• W2040338617 cites W2148547471 @default.
• W2040338617 cites W2159922234 @default.
• W2040338617 cites W2162381934 @default.
• W2040338617 cites W2177113479 @default.
• W2040338617 cites W2179490372 @default.
• W2040338617 cites W2183787908 @default.
• W2040338617 cites W2184631836 @default.
• W2040338617 cites W2187077780 @default.
• W2040338617 cites W2310361929 @default.
• W2040338617 cites W2314071700 @default.
• W2040338617 cites W2317657624 @default.
• W2040338617 cites W2332537490 @default.
• W2040338617 cites W2337813182 @default.
• W2040338617 cites W2416842606 @default.
• W2040338617 cites W4300776197 @default.
• W2040338617 doi "https://doi.org/10.1002/hep.1840140515" @default.
• W2040338617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1937389" @default.
• W2040338617 hasPublicationYear "1991" @default.
• W2040338617 type Work @default.
• W2040338617 sameAs 2040338617 @default.
• W2040338617 citedByCount "60" @default.
• W2040338617 countsByYear W20403386172012 @default.
• W2040338617 countsByYear W20403386172013 @default.
• W2040338617 countsByYear W20403386172014 @default.
• W2040338617 countsByYear W20403386172016 @default.
• W2040338617 countsByYear W20403386172019 @default.
• W2040338617 crossrefType "journal-article" @default.
• W2040338617 hasAuthorship W2040338617A5006020968 @default.
• W2040338617 hasAuthorship W2040338617A5025193144 @default.
• W2040338617 hasAuthorship W2040338617A5036912327 @default.
• W2040338617 hasAuthorship W2040338617A5050671359 @default.
• W2040338617 hasAuthorship W2040338617A5057513705 @default.
• W2040338617 hasAuthorship W2040338617A5057727335 @default.
• W2040338617 hasAuthorship W2040338617A5065857081 @default.
• W2040338617 hasAuthorship W2040338617A5069097596 @default.
• W2040338617 hasConcept C126322002 @default.
• W2040338617 hasConcept C134018914 @default.
• W2040338617 hasConcept C134651460 @default.
• W2040338617 hasConcept C150903083 @default.
• W2040338617 hasConcept C181199279 @default.
• W2040338617 hasConcept C185592680 @default.
• W2040338617 hasConcept C207001950 @default.
• W2040338617 hasConcept C2776329913 @default.
• W2040338617 hasConcept C2778163477 @default.
• W2040338617 hasConcept C2778620825 @default.
• W2040338617 hasConcept C2778697171 @default.
• W2040338617 hasConcept C2779399885 @default.
• W2040338617 hasConcept C2780361610 @default.
• W2040338617 hasConcept C2780749602 @default.
• W2040338617 hasConcept C2780965833 @default.
• W2040338617 hasConcept C2781089062 @default.
• W2040338617 hasConcept C2781109383 @default.
• W2040338617 hasConcept C55493867 @default.
• W2040338617 hasConcept C71924100 @default.

• next